Storia in 20 fonti

Revolution Medicines gets FDA nod for targeted pancreatic cancer drug | CNN

The U.S. Food and Drug Administration on Wednesday approved Revolution Medicines’ targeted drug for adults with metastatic pancreatic cancer who have received prior treatment or ‌cannot receive combination chemotherapy.

Raccontata da

thestar.com+8 altre

Confronto fonti

6 prospettive sulla stessa storia

AI · summaries

cnn.comStai leggendo11 h fa

Revolution Medicines gets FDA nod for targeted pancreatic cancer drug | CNN

originale

Timeline cronologica

mercoledì 26 agosto 2026·biopharmadive.com
Revolution drug heralded as a pancreatic cancer breakthrough cleared by FDA
Rasonque’s speedy approval — just a month after a completed submission — represents a paradigm shift for a notoriously deadly cancer and begins what analysts see as a highly…
mercoledì 26 agosto 2026·healio.com
Rasonque nabs FDA approval for previously treated metastatic pancreatic adenocarcinoma
The FDA has approved a first-in-class targeted therapy for adults with metastatic pancreatic adenocarcinoma. Daraxonrasib (Rasonque, Revolution Medicines), an RAS inhibitor,…

Revolution Medicines gets FDA nod for targeted pancreatic cancer drug | CNN

Confronto fonti

Revolution Medicines gets FDA nod for targeted pancreatic cancer drug | CNN

Timeline cronologica

Revolution drug heralded as a pancreatic cancer breakthrough cleared by FDA

Rasonque nabs FDA approval for previously treated metastatic pancreatic adenocarcinoma

Revolution Medicines gets FDA nod for targeted pancreatic cancer drug

Revolution Medicines Wins FDA Nod for First-Of-Its-Kind Pancreatic Cancer Drug - Revolution Medicines (NA

Revolution Medicines gets FDA nod for targeted pancreatic cancer drug | The Jerusalem Post

FDA approves ‘game-changing’ pancreatic cancer drug

FDA approves Revolution Medicines' daraxonrasib for pancreatic cancer

FDA Approves Pancreatic Cancer Drug That Could Double Survival Time—What To Know About Rasonque

'Grand Slam' Pancreatic Cancer Drug Wins FDA Approval

FDA approves landmark pancreatic cancer drug that's shown to improve survival

FDA approves new pancreatic cancer drug expected to usher in new era of treatment

FDA approves Revolution Medicines' pancreatic cancer drug, ushering in new era of KRAS therapy

FDA greenlights Revolution Medicines' pancreatic cancer gamechanger

FDA approves breakthrough drug to treat advanced pancreatic cancer

Revolution Medicines gets FDA nod for targeted pancreatic cancer drug | CNN

Revolution Medicines gets FDA nod for targeted pancreatic cancer drug

FDA approves landmark pancreatic cancer drug that’s shown to improve survival

Tumore del pancreas, via libera negli Usa alla prima terapia mirata contro il gene killer RAS

Revolution Medicines gets FDA nod for targeted pancreatic cancer drug | The Jerusalem Post

New hope for pancreatic cancer patients after FDA approves drug to improve survival

FDA approves ‘game-changing’ pancreatic cancer drug

FDA approves Revolution Medicines' daraxonrasib for pancreatic cancer

Revolution Medicines Wins FDA Nod for First-Of-Its-Kind Pancreatic Cancer Drug - Revolution Medicines (NA

FDA approves groundbreaking pancreatic cancer drug

FDA approves new treatment for those with advanced pancreatic cancer - UPI.com